Acellular and Dermal Replacement from Human Source Market
Acellular and Dermal Replacement from Human
Source Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Acellular and Dermal Replacement from Human Source
Market Size and Growth
The Acellular and Dermal Replacement from Human Source market is experiencing steady growth due to increasing demand for skin grafts in surgical procedures. The market size is projected to reach $X million by 2025, driven by advancements in tissue engineering and rising incidence of burns and ulcers.
Companies Covered (Covid 19 Impact Covered)
◍ MTF Biologics
◍ Allosource
◍ Parametrics Medical
◍ LifeNet Health
◍ Gunze
◍ Tissue Regenix
◍ Zimmer Biomet
◍ Integra LifeSciences
◍ Organogenesis
◍ Flower Orthopedics
◍ Promethean
◍ Wright Medical Group
◍ Aziyo Biologics
◍ RTI Surgical
◍ MiMedx Group
◍ Tides Medical
◍ Ventris Medical
◍ Vivex Biomedical
MTF Biologics, Allosource, LifeNet Health, and other companies provide acellular and dermal replacement products derived from human sources. These companies develop innovative solutions for wound care, orthopedic, and plastic surgery procedures. They contribute to the growth of the market by offering high-quality products and expanding their distribution networks.
- MTF Biologics: $143 million in sales revenue
- Allosource: $117 million in sales revenue
- LifeNet Health: $95 million in sales revenue
Market Segmentation
By Application
◍ Hospitals
◍ Clinics
By Product
◍ Human Dermis
◍ Human Placental Membrane
Request Sample Report